Pharma Journalist -

Genezen and Optieum Biotechnologies, Inc. (Optieum) announced a partnership for cGMP manufacturing of the lentiviral vector (LVV) construct used in the production of OPTF01, a novel…
Read More...

Adcentrx Therapeutics, a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, announced that…
Read More...

Opus Genetics, Inc. a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other ophthalmic disorders,…
Read More...

BioVaxys Technology Corp. and Sona Nanotech Inc. have announced a research collaboration to develop innovative cancer therapeutics by combining BioVaxys' DPX immune-educating platform…
Read More...

AdvanCell has amassed a great amount of funding recently from $18M in Federal Funding just this week and $112M Series C Financing. What led such financing? We received non-dilutive…
Read More...

Alterity Therapeutics has received Fast Track designation from the FDA for its investigational drug, ATH434, as a potential treatment for Multiple System Atrophy (MSA), a…
Read More...

Novo Nordisk has announced that the FDA has accepted the New Drug Application (NDA) for a once-daily 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in…
Read More...

TAE Life Sciences and The Ohio State University Comprehensive Cancer Center have announced a landmark collaboration focused on advancing boron-based drug innovation for Boron Neutron…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI™…
Read More...

VERAXA Biotech AG, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp., announced a co-discovery alliance with…
Read More...